Furthermore, we analyzed the expression of METTL3 in diverse pathological stages of HCC and found that its expression was significantly higher in stage III and IV HCC compared to stage I and II (Fig. 1B). The gene discussed is METTL3; the disease is hepatocellular carcinoma.